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Abstract
A major challenge in the post-genomic era is the development of experimental
approaches to monitor the properties of proteins on a proteome-wide level. It would
be particularly useful to systematically assay protein subcellular localization, post-
translational modiﬁcations and protein–protein interactions, both at steady state and
in response to environmental stimuli. Development of new reagents and methods
will enhance our ability to do so efﬁciently and systematically. Here we describe
the construction of two collections of budding yeast strains that facilitate proteome-
wide measurements of protein properties. These collections consist of strains with
an epitope tag integrated at the C-terminus of essentially every open reading frame
(ORF), one with the tandem afﬁnity puriﬁcation (TAP) tag, and one with the green
ﬂuorescent protein (GFP) tag. We show that in both of these collections we have
accurately tagged a high proportion of all ORFs (approximately 75% of the proteome)
by conﬁrming expression of the fusion proteins. Furthermore, we demonstrate
the use of the TAP collection in performing high-throughput immunoprecipitation
experiments. Building on these collections and the methods described in this paper,
we hope that the yeast community will expand both the quantity and type of proteome
level data available. Copyright  2005 John Wiley & Sons, Ltd.
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Introduction
The complete sequencing of the Saccharomyces
cerevisiae genome in 1996 (Goffeau et al., 1997)
enabled a new era of global biological analysis of
this organism. Sequence analysis of the genome
has provided a wealth of information relevant to
many aspects of yeast biology, most recently in
comparison to the genomes of other yeast species
(Brachat et al., 2003; Cliften et al., 2003; Kellis
et al., 2003). The development of whole genome
transcriptional proﬁling using DNA microarrays
has provided tools for assessment of the global
transcriptional proﬁle under different experimental
conditions (DeRisi et al., 1997; Lockhart et al.,
1996; Schena et al., 1995). This approach has been
extremely effective in understanding many biolog-
ical processes.
There are, however, limitations to microarray
analysis. Although the transcriptional proﬁle of
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an organism is informative, many biological
processes do not produce readily interpretable
transcriptional readouts. Additionally, the protein
effectors of biological processes in the cell cannot
be directly monitored through the transcriptional
proﬁle. It would be particularly informative to be
able to systematically monitor post-translational
modiﬁcations, localization and protein–protein
interactions in order to understand how the
dynamic properties of proteins allow them to carry
out biological processes.
Part of what makes microarray analysis possible
is the chemical similarity and stability of nucleic
acids. Despite the fact that these genes encode pro-
teins of diverse composition, structure and func-
tion, the associated nucleic acids have virtually
identical chemical properties. As a result, chemical
manipulations can be done for all genes in parallel,
simply by separating the nucleic acids spatially.
The same type of global analysis has been
extremely challenging to achieve for proteins. The
diversity of protein structure, chemical composi-
tion and stability makes generalized manipulation
difﬁcult. Further, the behaviour of proteins in iso-
lation is frequently not identical to their activity
in the context of the cellular milieu. Mass spec-
trometry and two-dimensional electrophoresis have
been used with some success in global protein
analysis (Aebersold and Mann, 2003), but have
been hampered by the complexity of the proteome,
and thus far have not been capable of analy-
ses of a truly global nature. In addition, these
techniques have a somewhat limited scope in the
types of protein characteristics they are capable
of measuring. Some groups have created puriﬁed
protein libraries (Martzen et al., 1999) or pro-
tein microarrays (MacBeath and Schreiber, 2000;
Phizicky et al., 2003; Zhu et al., 2001), but these
approaches have suffered from both the signiﬁcant
effort involved in purifying the proteins and the
inherent caveats of working with proteins in vitro.
A further problem that has plagued all of these
approaches has been difﬁculty in accurately assess-
ing coverage of the proteome.
It would therefore be valuable to have a system
that enabled systematic high-throughput analysis of
the yeast proteome, both in vivo and in vitro. One
could construct such a system by fusing a constant
epitope tag to all proteins, in essence making these
proteins more chemically similar to each other.
Such similarity would enable systematic manipu-
lation, puriﬁcation or analysis of these proteins by
a single method.
Here we describe the design and synthesis of
a set of oligonucleotide primers useful for the
genomic integration of DNA coding for any epitope
tag at the C-terminus of every ORF in the yeast
genome. Further, we describe the construction of
two collections of yeast strains, one with the TAP
tag and one with GFP tag, and the high-throughput
technology and methodology that enabled the con-
struction of these collections by a small team in
a relatively short period of time. Lastly, we dis-
cuss the utility of these collections in the system-
atic execution of high-throughput biochemical and
microscopic assays of the yeast proteome.
Materials and methods
Use of robotics and other high-throughput
tools
In designing the oligonucleotides and the collec-
tions, as well as in developing the methodology for
the creation and use of these collections, we made
every effort to utilize available high-throughput
technologies. The collection was designed in 96-
well format to enable efﬁcient oligonucleotide syn-
thesis using a 96-well DNA synthesizer (GeneMa-
chines Polyplex) and subsequent liquid handling
by a robotic 96-well pipettor (Beckman Biomek
FX). The Biomek FX was used for almost all
liquid handling applications, including resuspend-
ing oligonucleotides, setting up all PCRs, loading
agarose gels, transformations, inoculating cultures
and adding lysis buffer to cell pellets. In cases
where the Biomek FX could not be used, we
instead employed electronic multichannel pipettors,
for applications such as loading SDS-PAGE gels
and dispensing buffers. In minimizing the number
of manual steps performed, we were able to both
optimize the efﬁciency of construction and mini-
mize the opportunity for human error. This enabled
the entire process to be completed in-house by a
relatively small team.
Oligonucleotide primer design and synthesis
The yeast genome sequence, as well as the coor-
dinates of all ORFs, were obtained by down-
load from the Saccharomyces Genome Database
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(Dolinksi et al.; ftp://ftp.yeastgenome.org/yeast/)
on 17 April 2001. We removed all mitochondrial
genes, as well as those encoding Ty elements.
We then divided the ORFs into two categories:
soluble and putative membrane proteins, reason-
ing that having membrane proteins as a separate
group would facilitate any modiﬁcations in bio-
chemical assays needed for these proteins. The
following criteria were used to put ORFs into the
putative membrane category: (a) any protein exper-
imentally determined to be an integral membrane or
membrane-associated protein; (b) any protein with
homology to a membrane or membrane-associated
protein; and (c) any protein with 2 putative trans-
membrane domains which appeared in the microar-
ray data of polysome-associated RNAs (Diehn
et al., 2000).
Within the soluble and membrane categories, we
ordered genes by size with the largest ﬁrst, and
then divided ORFs into groups of 96 to facili-
tate subsequent manipulations in 96- and 384-well
plates. Each ORF is designated by a plate num-
ber and coordinates within that plate. All reagents
and strains relevant to a given ORF occupy the
same unique coordinates. This facilitated subse-
quent manipulations by the Biomek FX.
We used the ‘Promoter’ program (courtesy of Joe
DeRisi, publicly available at: http://derisilab.ucsf.
edu) to extract the last 40 nucleotides (exclud-
ing the stop codon) of each ORF, as well as
40 nucleotides of genomic sequence immedi-
ately following the stop codon of each ORF.
We added the constant forward sequence from
the ‘Pringle’ oligonucleotide-directed homologous
recombination system (Longtine et al., 1998) to
the last 40 nucleotides of each ORF to create
the F2 oligo sequence, and the reverse comple-
ment of the 40 nucleotides following each ORF
to the constant reverse sequence to create the R1
oligo sequence. To design the sequence of the
unique check primer for each ORF, we utilized
Primer 3.0 (Rozen and Skaletsky; http://www-
genome.wi.mit.edu/genome software/other/pri-
mer3.html), selecting oligonucleotide primers with
melting temperatures of 60 ◦C and which hybridize
at 400–650 nucleotides upstream of the stop codon
for each ORF. We note that this approach was used
for all ORFs, including those representing repeated
genes. The oligonucleotide sequences are available
in the Supplementary Materials (http://www.inter-
science.wiley.com/jpages/1531–6912/suppmat),
and also can be downloaded from the website
accompanying the research papers (http://yeastgfp.
ucsf.edu).
Oligonucleotides were synthesized on a Gene-
Machines Polyplex 96-well oligonucleotide synthe-
sizer, which was modiﬁed to accommodate larger
reagent bottles required for 60-mer synthesis. All
DNA synthesis reagents used were from Glen
Research. We used a protocol (see Supplementary
Materials; http://www.interscience.wiley.com/
jpages/1531–6912/suppmat) optimized for pro-
ducing full length 60-mers without a need for
changing reagent bottles (involving more and
longer coupling steps with less volume), enabling
us to run the machine overnight, which allowed
for the efﬁcient synthesis of the 1246860-base and
6234 20-base oligonucleotides required.
Synthesized oligonucleotides were cleaved off
the solid synthesis support by incubating three
times with 100 µlN H 4OH for 10 min, followed
by collection into a deep well 96-well plate
with a vacuum manifold (Millipore). The oligos
were then deprotected by heating at 65 ◦C for
15–24 h, and lyophilized in a Sorvall SpeedVac
AES2010 to remove the NH4OH. Prior to use,
oligonucleotides were resuspended to a concen-
tration of 100 µM with deionized water (typically
200–300 µl, depending on the scale of DNA syn-
thesis).
Construction of collections
We performed PCR and transformation in 96-well
format as follows: F2 and R1 oligos were combined
to working concentrations of 5 µM each. 10 µlo f
the primer combination were added to 40 µlo fa
PCR mix [19.5 µlH 2O, 5 µl1 0 × Pwo buffer, 5 µl
20 mM MgCl2,5 µl2 m M dNTPs, 5 µl plasmid
template DNA (∼2 ng/ml), 0.5 µl Expand DNA
polymerase] aliquotted to 96-well microplates in
order to amplify the desired tag. For PCR, we
used an MJ Research Tetrad thermal cycler with
the following program: 94 ◦C 3 min, 10× (94 ◦C
15 s, 50 ◦C3 0s ,7 2 ◦C 2 min), 15× (94 ◦C1 5s ,
72 ◦C 2 min +5 s/cycle), 72 ◦C 10 min. Following
PCR, we checked for a product of correct size
using 96-well agarose gels (Amersham Ready to
Run system) loaded with the Biomek FX.
These PCR products were then transformed
into our base strain (ATCC #201388: S288C,
Copyright  2005 John Wiley & Sons, Ltd. Comp Funct Genom 2005; 6: 2–16.Preparation and application of epitope-tagged budding yeast strain collections 5
MATa his3 1 leu2 0 met15 0 ura3 0; Brach-
mann et al., 1998). Cells were grown to OD600
of 0.7–0.8 in YEPD; each transformation in the
96-well plate required 3 ml of starting culture.
After being pelleted at ∼1000 × g at room tem-
perature, cells were washed twice in 1/10 of the
original culture volume of 100 mM lithium acetate
and resuspended in 1/100 of the original cul-
ture volume of 100 mM lithium acetate. For each
transformation, we added 15 µl unpuriﬁed PCR
product to 183 µl aliquots of the following trans-
formation recipe, mixed by vortexing at temper-
ature and scaled appropriately for 96-well for-
mat: 100 µl 50% weight/volume PEG (MW 3350,
freshly prepared and ﬁltered at 0.2 µm), 15 µl1M
lithium acetate, 20 µl salmon sperm carrier DNA
(2 mg/ml), 18 µl DMSO, and 30 µl yeast cell sus-
pension. We then performed incubations (30◦C for
30 min, followed by 42 ◦C for 15 min) for trans-
formation in the thermal cycler. Cells were pelleted
in the microplates at ∼1000 × g at room tempera-
ture, resuspended in 100 µl water, and plated man-
ually on standard yeast synthetic medium plates
lacking histidine (SD–His) to select for genomic
integrants.
After growth for 3 days, transformations typi-
cally yielded 5–100 colonies. We selected up to
six individual transformants for each ORF and
streaked onto fresh selective medium. After sub-
sequent growth, we performed whole-cell PCR on
each transformant to determine whether the tag had
integrated at the correct locus. A small aliquot
of freshly grown cells was resuspended in 5 µl
water and boiled in 96-well format (99 ◦C for
5 min in the thermal cycler). 5 µl boiled cells and
2.5 µl5µM unique ‘check’ oligos were added to
PCR mix (13 µlH 2O, 2.5 µl1 0 × Taq buffer, 1.5 µl
2m M dNTPs, 0.25 µl5 0 µM ‘F2CHK’ primer,
0.25 µl 5U/µl Taq Polymerase, 0.05 µl 10 mg/ml
RNase) and PCR was performed [94◦C 2.5 min,
35× (94 ◦C4 5s ,5 5 ◦C4 5s ,7 2 ◦C 1 min), 72 ◦C
10 min]. We analysed the results of these PCRs
by 96-well agarose gel electrophoresis, identifying
correct integrants by the presence of a PCR product
of appropriate size.
For construction of the GFP collection, we
used much the same method, except individual
transformants were picked and directly inoculated
into 600 µl SD-His medium for overnight growth.
We centrifuged 200 µl of these cultures in 96-well
PCR plates to pellet cells, removed the supernatant,
and lysed the cells in 20 µl 0.2% SDS at 99 ◦C
for 10 min in the PCR machine. We then used
0.6 µl of this lysate as template for a 20 µl PCR
(16.2 µlH 2O, 2 µl1 0 × Taq buffer, 0.6 µl2m M
dNTPs, 0.2 µl each 50 µM oligonucleotide primer,
0.2 µl5U / µl Taq polymerase, 0.04 µl 10 mg/ml
RNAse) to conﬁrm correct integration of the tag.
The presence of a PCR product was analysed by
96-well agarose gel electrophoresis.
Assembly and growth
To assemble these strain collections into 96-well
plates, we selected two correct integrants (when
possible) for each ORF and resuspended cells in
0.5× SD-His +15% glycerol. The plate number
and coordinates were maintained for each ORF,
resulting in an ‘A’ and ‘B’ collection for each set of
epitope-tagged strains, which we froze at −80◦C.
For the GFP strains, we assembled the A and B
collections directly from the liquid cultures used for
conﬁrmation PCR, mixing saturated cultures with
30% glycerol and freezing.
Subsequent growth was achieved by thawing
the glycerol stocks and either inoculating liquid
cultures with a Biomek FX robot or spotting onto
YEPD plates with a 96-well pinning tool. To grow
these cultures in high-throughput format, we used a
GeneMachines HiGro growth chamber. Typically,
cultures were 1.5–2.0 ml, and cells were grown at
30 ◦C and 500 rpm. Under these conditions, cells
grew with the same growth rate as liquid cultures
in standard ﬂasks (data not shown). We sometimes
used Teﬂon-coated magnetic beads in each well to
enhance mixing of the culture. Addition of these
beads did not have an effect on growth rate (data
not shown), but did prevent settling of cells that
began to occur in late log phase.
Immunoblot analysis of the TAP collection
To analyse the TAP collection by immunoblotting,
200 µl aliquots of YEPD medium in a 96 well
plate were inoculated with cells from a plate with
a 96-well pinning tool and allowed to grow to
saturation overnight. We diluted these cultures to
OD600 =∼ 0.1 into 1.8 ml YEPD in 2 ml deep-
well 96-well plates and grew them to logarithmic
phase (0.8 < OD600 < 1.0) at 30 ◦C and 500 rpm
in a GeneMachines HiGro Shaker. Log phase cul-
tures were centrifuged to pellet the yeast cells.
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We removed the medium supernatant and added
50 µl hot SDS lysis buffer (50 mM Tris, pH 7.5,
5% SDS, 5% glycerol, 50 mM DTT, 5 mM EDTA,
bromophenol blue, 2 µg/ml leupeptin, 2 µg/ml pep-
statin A, 1 µg/ml chymostatin, 0.15 mg/ml benza-
midine, 0.1 mg/ml pefabloc, 8.8 µg/ml aprotinin,
3 µg/ml anipatin) and boiled (99 ◦C for 10 min in
the thermal cycler). These lysates were centrifuged,
and the supernatant was kept and frozen at −80◦C.
We loaded 13 µl of these lysates on 26-well
4–15% gradient precast Criterion gels (Bio-Rad)
with a multi-channel pipettor (Matrix Technologies
Impact2). Gels were run and transferred to PVDF
membranes with a Transblot SD semi-dry blot-
ter (Bio-Rad). Immunoblot analysis was performed
using a primary antibody mixture of a rabbit poly-
clonal afﬁnity-puriﬁed antibody to the calmodulin-
binding peptide (CBP) portion of the TAP tag
(1:5000 dilution) and an anti-hexokinase antibody
(US Biological, 1:50000) as a loading control
and quantitation standard. A horseradish peroxi-
dase (HRP) conjugated goat anti-rabbit antibody
(Bio-Rad) was used as a secondary antibody, and
the SuperSignal West Femto Maximum Sensitiv-
ity ECL substrate (Pierce) was used for detection.
Images were collected with a CCD-based imag-
ing system (Alpha Innotech Fluorochem 8800) and
analysed with the FluoroChem FC software (Alpha
Innotech).
Fluorescence microscopic analysis of the GFP
collection
We grew cells from the GFP collection to log
phase in the same way, except in SD-His medium.
Aliquots of these cultures [100 µl of a 1:10
dilution in SD-His with a ﬁnal concentration
of 1 µg/ml 4 ,6-diamidino-2-phenylindole (DAPI)]
were analysed in 96-well glass-bottomed micro-
scope slides (BD Falcon #357311) pre-treated with
concanavalin A (50 µg/ml in water) to ensure cell
adhesion. Prior to using the slides, we added 100 µl
concanavalin A solution to each well, incubated at
room temperature for at least 30 min, washed ﬁve
times with distilled water, removed excess liquid
by vigorous shaking, and dried the plates right-
side up and covered by a lid overnight. We imaged
cells using a Nikon TE200/300 inverted micro-
scope with a 100× oil-immersion objective (the
slide bottoms were painted with immersion oil),
and made use of scripting functions in the Meta-
Morph version 4.6r8 imaging software in order to
automate most of this process. GFP (Chroma ﬁlter
set 41020, exciter HQ480/20x, dichroic Q495LP,
emitter HQ510/20m) and DAPI (Chroma ﬁlter set
86010, exciter S375/20×, dichroic 86010bs, emit-
ter S415/24m) ﬂuorescence images (2 s exposure),
as well as differential interference contrast (DIC)
images (10 ms exposure), were collected for each
strain and analysed for expression and subcellular
localization (Huh et al., 2003). For co-localization
analysis (Huh et al., 2003), RFP was visualized
using Chroma ﬁlter set 86010, exciter S580/20×,
dichroic 86010bs, and emitter S630/60m and GFP
was visualized using Chroma ﬁlter set 86010,
exciter S492/18x, dichroic 86010bs, and emitter
S530/40m; use of the same dichroic mirror mini-
mized the time lapse between ﬂuorescent images.
Reorganization of TAP collection
With the TAP immunoblot data in hand
(Ghaemaghammi et al., 2003), we reorganized
the TAP collection strains according to abun-
dance. Based on our measured protein expres-
sion levels, we divided the strains into ﬁve dif-
ferent expression level categories, designated GS1,
GS2, GS3, GS4 and GS5. GS1 is the high-
est expression category and GS2, GS3 and GS4
have successively lower expression levels, with
upper cutoffs of 3.5 × 104,4 .75 × 103 and 1.38 ×
103 molecules/cell respectively. The GS5 cate-
gory includes all ORFs that could be visualized
on the blots but whose abundance could not be
quantiﬁed, either because the expression level was
close to background or there were other techni-
cal complications with the quantitation (e.g. the
protein did not run primarily as a single band).
Within each abundance category, the proteins are
arranged based on predicted size from largest to
smallest. The membrane proteins have been placed
at the end of each category, also arranged from
large to small. The organization of the TAP col-
lection is available in the supplementary mate-
rials (http://www.interscience.wiley.com/jpages/
1531–6912/suppmat).
96-well growth and native extract preparation
To grow cells for extract preparation, we ﬁrst inoc-
ulated 600 µl YEPD liquid cultures from a YEPD
plate, using a 96-well pinning tool. These cultures
were allowed to grow to saturation overnight on the
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benchtop with no agitation. The next morning we
diluted these cultures into six deep-well 96-well
plates, with 1.8 ml YEPD medium in each well,
to an OD600 = 0.1–0.2, and grew to log phase
(0.8 < OD600 < 1.0) at 30 ◦C and 500 rpm in a
GeneMachines HiGro Shaker. When cultures had
reached log phase, we centrifuged the plates at
3000 rpm for 10 min and aspirated the medium.
The cell pellets were resuspended in 150 µl cold
sorbitol buffer (1.2 M sorbitol, 0.1 M KPO4,p H
7) +2 µl/ml 2-mercaptoethanol. We then com-
bined the cell suspensions from six 96-well plates,
maintaining the coordinates, and centrifuged and
aspirated again. These pellets were then resus-
pended in 150 µl cold sorbitol buffer with 2 µl/ml
2-mercaptoethanol and 60 µl/ml lyticase (Haswell
and O’Shea, 1999), and transferred to a 96-well
PCR plate. We incubated these plates at 30 ◦C
for 15 min in the thermal cycler, then centrifuged
gently (1000 × g) for 10 min. After aspirating the
supernatant, the pellets were washed gently in sor-
bitol buffer, frozen in liquid nitrogen and stored at
−80 ◦C.
To lyse the cells, we resuspended the thawed
cell pellets in 100 µl hypotonic lysis buffer (50 mM
Tris, pH 7.5, 5 mM MgCl2,5m M EGTA, 1 mM
EDTA, 0.1% Triton X-100, 1 mM 2-mercaptoetha-
nol, 2 mM PMSF, 2.5 mM benzamidine, 1 µg/ml
leupeptin, 1 µg/ml pepstatin). After incubation on
ice for 10 min, we added 20 µl buffer plus 0.9 M
NaCl (to make the ﬁnal buffer 150 mM NaCl) and
incubated on ice for another 10 min. We then cen-
trifuged at 4000 rpm in a Beckman RC-3B swing-
ing bucket rotor ﬁtted with 96-well plate carriers
for 20 min to pellet cellular debris. Following cen-
trifugation, we removed 100 µl lysate to a new
96-well plate containing 25 µl 50% glycerol in each
well, and kept a small aliquot to measure protein
concentration by Bradford assay. These extracts
were frozen in liquid nitrogen and stored at −80◦C.
Each well contained 125 µl total extract and typi-
cally were ∼10 mg/ml.
Multiplexed immunoprecipitations
To perform high-throughput immunoprecipitations,
we ﬁrst prepared native extracts as above, except
we combined cell pellets from six different cul-
tures into one plate. The result is that each well
contains a total of 125 µl ∼ 10 mg/ml extract, but
derived from a mixture of six different TAP-
tagged strains. We combined strains with approxi-
mately equal expression levels of the fusion pro-
tein in order to minimize dominance of well-
expressed proteins or loss of minimally expressed
proteins.
To perform the immunoprecipitation reactions,
we ﬁrst diluted extracts in 1 ml deep-well 96-
well plates to a total volume of 560 µl with P
buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM
MgCl2,5 m M EGTA, 1 mM EDTA, 0.1% Tri-
ton X-100, 1 mM 2-mercaptoethanol, 2 mM PMSF,
2.5 mM benzamidine, 1 µg/ml leupeptin, 1 µg/ml
pepstatin). We then added 3 µg biotin-conjugated
Human IgG (Jackson Immunoresearch), and incu-
bated extracts for 30 min at 4 ◦C. 40 µlo fa2 5 %
suspension of streptavidin beads (Amersham Phar-
macia) was then added to each well. We incubated
the plate at 4 ◦C for another 30 min, vortexing very
gently three or four times during this period to
resuspend the beads.
We then transferred the reactions with a multi-
channel pipettor to a ﬁlter plate (Orochem cata-
logue no. OF1100). This type of plate contains
96 wells, each with a small frit above an open-
ing at the bottom of each well. We placed this
plate on a vacuum manifold; applying a vacuum
allows for the removal of the supernatant but reten-
tion of the beads. Beads were washed four times
with 400 µl of PDMS buffer (P buffer + 1% Tri-
ton X-100 + 300 mM NaCl). We then centrifuged
the plate brieﬂy (1000 × g for 1 min) to remove
any residual liquid remaining in or around each
well. 10 µl sample buffer was added to each well,
and the plate was vortexed to resuspend the beads
in the sample buffer. The plate was allowed to
stand at room temperature for 5 min, and then cen-
trifuged (1000 × g for 2 min) on top of a shallow
96-well plate to collect the eluate. This process was
repeated again, to generate a total elution volume
of 20 µl.
To analyse the results of the multiplex immuno-
precipitation, the samples were run on 26-well Cri-
terion SDS-PAGE gels (Bio-Rad), and transferred
to nitrocellulose in 20 mM NaPO4, pH 6.8, buffer
with a BioRad Transblot apparatus. We performed
immunoblot analysis by probing with Rabbit Fc
(Jackson Immunoresearch; 1:10000 dilution of
3.8 mg/ml stock in TBST + 5% non-fat dry milk),
an HRP-conjugated goat anti-rabbit Fc secondary
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antibody (Jackson Immunoresearch; 1:50 000 dilu-
tion of a 1 mg/ml stock in TBST + 5% milk), and
the SuperSignal West Femto Maximum Sensitiv-
ity ECL substrate (Pierce). Images were collected
with a CCD camera (Alpha Innotech Fluorochem
8800).
Availability of TAP and GFP collections
The TAP collection is available from Open Biosys-
tems (http://www.openbiosystems.com) and the
GFP collection is available from Invitrogen (http:
//www.invitrogen.com).
Results and discussion
Collection design and oligonucleotide synthesis
To create a collection of tagged yeast strains,
we utilized oligonucleotide directed homologous
recombination (Figure 1A) (Longtine et al., 1998)
to integrate an epitope tag at the C-terminus of
each ORF. Brieﬂy, 60-mer oligonucleotide primers
(the ‘F2’ and ‘R1’ primers) are designed which
contain both a variable sequence, homologous to
the gene of interest, and a constant sequence, which
enables PCR ampliﬁcation of sequence coding for
the desired tag and a nutritional marker used to
select for integrants. Homologous sequences in
the oligonucleotides direct integration of the tag
at the desired location in the genome. Nutritional
selection is used to isolate the integrants, and
integration at the correct locus is then conﬁrmed,
using PCR with one primer in the tag and one
speciﬁc to the targeted ORF (Figures 1B, 2A).
We chose to tag the C-terminus of each ORF
so that the endogenous promoter would remain
intact, and to minimize the impact on the signal
sequence of secreted and membrane proteins. We
therefore designed and synthesized the required
oligonucleotides for each ORF in the yeast genome
(see Methods for details). Although we chose to
construct two collections, one with the TAP tag and
the other with the GFP tag, this oligonucleotide set
could be used to construct a collection of strains
with any desired tag integrated at the C-terminus
of each ORF.
An important consideration in the design of the
collections was the ability to take advantage of
high-throughput and automation technologies. We
designed the oligos in 96-well format to be efﬁ-
ciently synthesized by a high-throughput synthe-
sizer, and developed methods for construction and
use of the collections based around liquid handling
robots and multi-channel pipettors. The use of these
tools was imperative in making a project of this
nature feasible. After reﬁnement of these methods
during construction of the TAP collection, the only
manual steps performed in the construction of the
GFP collection were plating transformations and
picking colonies.
Construction of the TAP and GFP collections
The ﬁrst round of construction of the TAP col-
lection was accomplished in about 4 months by a
team of six people. We subsequently further reﬁned
the protocol for the conﬁrmation PCR by grow-
ing individual transformants in liquid culture rather
than on solid medium, enabling all manipulations
to be performed by the Biomek FX liquid handling
robot. With this reﬁnement, as well as others, the
efﬁciency of the construction process was greatly
enhanced: the ﬁrst round of construction of the GFP
collection was carried out by two people in under
3 months. This oligo set and these methods could
therefore be useful in the efﬁcient construction of
new collections tailored to particular experiments.
After the ﬁrst round of construction of the
TAP collection, we successfully tagged 97% of
6234 ORFs, as assayed by genomic PCR. For the
GFP collection, we obtained PCR-positive clones
for 99% of ORFs. We also determined that the
frequency of obtaining a properly integrated strain
(assayed by genomic PCR) was roughly equivalent
between essential (93%) and non-essential (98%)
ORFs.
Conﬁrmation of correctly expressed fusion
proteins and reconstruction
We collected two PCR-positive clones (when pos-
sible) for each ORF, and assembled the strains into
an ‘A’ and ‘B’ set for each collection. In begin-
ning to work with these strains, we discovered
some inconsistencies in expression of tagged pro-
teins in different isolates from the same tagged
ORF. Speciﬁcally, we identiﬁed some cases in
which only one of the two isolates expressed the
protein of interest, despite the fact that correct
integration was conﬁrmed for both by genomic
PCR. After sequence analysis of representative
isolates, we identiﬁed sequence errors in the
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TAG HIS3
ORF X
ORF X
F2
R1
ORF X CHK
Amplify tag with F2 and R1 primers
Transform product into yeast
ORF X TAG HIS3
F2 CHK ORF X CHK
Confirmation PCR with
ORF X CHK and F2 CHK
TAP HIS3
TAP HIS3
TAP HIS3
TAP HIS3
plate on
selective medium
pick individual
colonies
check for correct
integration by PCR
keep 2 positives
transform ORF-specific
PCR product into yeast
check for expression by
immunoblot/microscopy
A
B
Figure 1. Schematic of construction and veriﬁcation process for strain collections. (A) PCR-mediated homologous
recombination. Three oligonucleotide primers are designed and synthesized for each ORF: the F2 and R1 oligos and a CHK
oligo. The F2 and R1 oligos, containing regions of homology to the ORF of interest, are used to amplify the desired tag and
a selectable marker; this PCR product then integrates into the genome at the C-terminus of the ORF of interest. The CHK
oligo, as well as an oligo within the tag, is used to verify integration at the desired location. (B) Generalized construction
process. We transformed the PCR-ampliﬁed tag into yeast, plated on selective medium, and then picked individual colonies
and veriﬁed correct integration of the tag. Correct integrants were then screened for expression of the protein fusion by
immunoblot or microscopy and a correctly expressing isolate was selected
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A
B
C
correct integrant
incorrect integrant
YJR117W "A"
YJR117W "B"
DAPI DIC GFP
HXK
Figure 2. Examples of veriﬁcation of integration and expression. (A) 96-Well agarose gel used to analyse check PCRs
to conﬁrm proper integration of the tag. Presence of band indicates proper integration, absence indicates improper
integration. (B) Immunoblot analysis of TAP collection isolates. Arrow indicates the hexokinase band used as a loading
control and quantitation standard. (C) Fluorescence microscopy of GFP collection isolates. Shown is an example in which
expression from the A collection did not match expression from the B collection
junction between the C-terminus of the protein
and the tag, or in the tag itself. The source of
these errors is presumably errors in the oligonu-
cleotides themselves or in the tag ampliﬁcation and
transformation process. Regardless, we concluded
that proper integration of the tag could only
be reliably conﬁrmed by analysing expression of
the fusion protein (by immunoblot for the TAP
collection, and ﬂuorescence microscopy for the
GFP collection).
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We analysed log phase cultures from the A and
B isolates of both collections for expression of
the tagged proteins. For the TAP collection, we
made SDS extracts and analysed these extracts by
SDS-PAGE followed by immunoblotting against
the TAP tag (Figure 2B). For the GFP collection,
we observed the tagged proteins by ﬂuorescence
microscopy (Figure 2C). A more thorough discus-
sion of these methods is in the Materials and meth-
ods section.
After this analysis, we were able to identify
which isolates of a particular ORF were correctly
expressing the tagged protein of interest. We
found that the frequency of ‘mistagged’ ORFs
was signiﬁcant. In the TAP collection, 21% of
PCR-positive ‘B’ isolates with a corresponding
expression-positive A isolate yielded no detectable
expression by immunoblot. This highlights the
importance of expression analysis in conﬁrming the
accuracy of these collections.
In cases where expression could not be con-
ﬁrmed for either isolate, we were unable to distin-
guish between two possibilities. First, it is possible
that neither isolate contained the correctly tagged
ORF. Alternatively, the protein could be correctly
tagged, but not expressed to detectable levels under
our growth conditions. We therefore compared our
results from both collections to determine if there
were cases in which expression of a given ORF
was detected in one collection but not the other.
Given that these collections were constructed with
the same oligo set, one would expect to obtain
similar results with the two collections. Although
these means of analysis are different and there-
fore may have different limits of detection, we
reasoned that if a tagged protein was detected in
one collection but not the other, it was probably
not tagged correctly in the collection in which it
was not detected.
With this information in hand, we undertook the
task of reconstructing those strains (708 for the
TAP collection, 759 for GFP) for which the ORF
fusion was detected in one collection but not the
other. In order to avoid again isolating strains that
did not correctly express the tagged protein of inter-
est, we omitted the conﬁrmation PCR and instead
analysed individual transformants by immunoblot-
ting or microscopy. After this process, 457 new
positives were obtained for the TAP collection, and
398 new positives were obtained for the GFP col-
lection.
Coverage of the proteome
In the construction of these collections, we mon-
itored our success rate at many steps in order to
assess the quality and utility of these collections in
performing proteome-wide studies (Table 1). While
we were able to obtain a 97% success rate by
genetic analysis, our subsequent expression anal-
ysis indicated that this is not the most accurate
metric for coverage of the proteome. Because of the
potential for errors in the oligonucleotides and in
the integration process, and the inability of genetic
analysis to uncover these errors, we feel that detec-
tion of expression of the fusion proteins is the most
accurate metric of coverage, especially considering
that utility of these collections in monitoring pro-
tein characteristics ultimately rests on the ability to
detect them.
By this metric, we detect 4251 proteins, or 68%
of 6234 annotated ORFs, in the TAP collection,
and 4156, or 67% of annotated ORFs, in the
Table 1. Details of success rate at various stages of construction for the TAP and GFP collections
TAP collection GFP collection
All ORFs Essential ORFs All ORFs Essential ORFs
#%# % #%# %
Total ORFs 6234 100 1100 100 6234 100 1100 100
Tag ampliﬁed with ORF speciﬁc PCR 6211 100 1096 100 ND ND
≥1 Transformants obtained 6047 97 1014 92 6151 99 1018 93
Positive by check PCR 6040 97 1003 92 6029 97 953 87
Positive by expression (ﬁrst round) 3811 61 723 66 3758 60 712 65
Positive by expression (after reconstruction) 4251 68 821 75 4156 67 827 75
Success rates for all ORFs and essential ORFs of each collection are displayed, as well as the associated percentage. ND, not determined.
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GFP collection (Ghaemmaghami et al., 2003; Huh
et al., 2003). Previously, we estimated that 525 of
the 6234 annotated ORFs are spurious (Ghaem-
maghami et al., 2003), a result similar to that
derived from a comparative genomics study (Kel-
lis et al., 2003). These observations suggest that
there are approximately 5700 protein-coding genes.
Therefore, we observe ∼75% of the proteome by
Western blot analysis of the TAP library and ∼73%
of the proteome by ﬂuorescence microscopic anal-
ysis of the GFP library. A total of 4517 ORFs,
or 79% of the proteome, were detected in at least
one collection (Ghaemmaghami et al., 2003). The
overlap between the proteins detected in these col-
lections [over 90% of ORFs detected in the GFP
collection were also detected in the TAP collection
(Ghaemmaghami et al., 2003; Huh et al., 2003)]
strengthens our conclusion that the collections rep-
resent a large majority of true protein-coding genes.
These numbers will undoubtedly improve as more
sensitive detection methods are developed (such as
immunoprecipitation followed by immunoblot) and
as expression in other growth conditions is exam-
ined.
However, some strains will certainly need to be
reconstructed. We sequenced the ORF-tag junction
and the tag for 35 strains for which the tagged
ORF is known or strongly predicted to code
for a protein, but the fusion protein was not
detected in either collection. Of three clones for
fusions of essential ORFs, two had mutations
and one did not. Of ﬁve clones for fusions of
ORFs with a high codon adaptation index (CAI),
four had insertions or deletions and one had a
non-synonymous substitution in the tag. Of 27
clones for fusions of ORFs coding for proteins
with a previously reported localization (Dolinksi
et al.; ftp://ftp.yeastgenome.org/yeast/), 20 had
mutations while seven did not. It is possible
that the oligonucleotide primers used to generate
these strains contained more errors, or that some
deleterious consequences of insertion of the tag
caused selection against correct integrants.
If we take our success rate for essential proteins
as a proxy of our overall success rate (since
essential proteins are presumably true ORFs and
expressed under normal growth conditions), our
collections represent 75% of the proteome for
the TAP collection and GFP collections. When
looking at both collections, at least one fusion
protein was detected for about 80% of essential
ORFs. The high percentage of essential ORFs
detected also indicates that the fusion protein is
likely functional in a high proportion of cases.
We conclude that these collections represent useful
representations of the proteome for use in global
analyses. In characterizing these collections, we
were also able to make quantitative measurements
of protein expression (Ghaemmaghami et al., 2003)
and describe cellular localization (Huh et al., 2003)
for the majority of the yeast proteome.
‘Multiplexed’ immunoprecipitations
In constructing these collections, we wished to not
only be able to perform descriptive analyses, but
also to do experiments systematically on the entire
proteome. Our hope was that standard laboratory
assays typically performed on a small number of
strains or proteins could be applied systematically
and efﬁciently to the entire proteome. The fact that
every strain in the TAP collection utilizes the same
tag enables a generalized method to be applied to
all strains to perform large-scale experiments in
parallel.
As a ﬁrst step, we developed high-throughput
methods to efﬁciently make extracts and immuno-
precipitate proteins (Figure 3A). Brieﬂy, this
involves growing 2 ml cultures to log phase in
96-well format, combining cell pellets from six dif-
ferent 96-well plates, and spheroplasting cells with
lyticase. We made extracts by osmotic lysis, pel-
leting cellular debris and keeping the supernatant.
Each well of these ‘multiplex’ extracts contains
extract from six different strains, and therefore six
different TAP-tagged proteins, facilitating the par-
allel immunoprecipitation of six different proteins
in each well of a 96-well plate. Immunoprecip-
itation in 96-well format, therefore, theoretically
enables the simultaneous pulldown of 576 proteins.
Utilizing the quantitative immunoblot data
obtained from screening the TAP collection
(discussed above), we reorganized the TAP
collection according to abundance. We divided the
strains into six abundance categories, and within
each category ordered the strains by size of the
tagged ORF. Because of this reorganization, the six
TAP-tagged proteins in each well of the multiplex
extracts are of approximately equal abundance in
extracts. Because the proteins are ordered by size
within each abundance category, the six proteins in
a given well also represent the maximal possible
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2 mL 96-well
culture plates
1 mL deep
well plate
Filter plate:
beads are retained
while liquid flows
through
Combine 6 plates into 1
and prepare extracts
Add lgG biotin and
streptavidin beads;
transfer to filter plate
A
B
Wash and elute;
analyze by SDS-PAGE
Figure 3. High-throughput ‘multiplex’ immunoprecipitations. (A) Schematic of process. Cultures from six 2 ml 96-well
plates are pelleted, combined and used to prepare extracts. IgG biotin and streptavidin beads are added and allowed to
bind, and then transferred to a ﬁlter plate that allows for retention of the beads. The beads are washed, and proteins are
eluted and analysed by SDS-PAGE and immunoblot. (B) Example immunoblot of results of multiplex immunoprecipitation
size distribution within the abundance category.
This facilitates the resolution of the individual
proteins in subsequent analysis by SDS-PAGE.
To test the feasibility of high-throughput
immunoprecipitations, we prepared multiplex
extracts and pulled down TAP-tagged proteins
as described in the methods. In this particular
experiment, the last column of the plate was left
empty to provide space for controls necessary
for a subsequent assay, so the theoretical
maximum number of proteins pulled down in
this reconstruction is 528 proteins. As shown in
Figure 3B, we were successfully able to pull down
a large number of proteins with this procedure.
To quantify the efﬁciency of the multiplex
pulldown, we counted the number of distinct bands
in each lane, and summed the total for this gel and
the entire plate. We cannot discount the possibility
that some of these bands may represent breakdown
products or modiﬁed proteins; nevertheless, due to
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the distinctness of the bands and the fact that they
migrate at the appropriate molecular weight, it is
likely that a signiﬁcant proportion represent full-
length proteins. It should be noted that because
immunoprecipitation efﬁciency and potential post-
translational modiﬁcation or breakdown product
formation is not identical for the six proteins in
each lane, the multiplexing technique is not meant
for comparisons between proteins within each lane,
but rather for comparisons across different lanes
(e.g. at different growth conditions or time points)
for the same protein. The gel shown contains 22
lanes, or one-quarter of the plate, so the theoreti-
cal maximum number of immunoprecipitated pro-
teins is 132. We are able to detect 111 distinct
bands in this gel, or 84% of possible proteins. In
immunoblots for the entire plate, we were able
to detect 452 distinct bands, representing 86%
of the 528 proteins possible. In separate experi-
ments in which we immunoprecipitated TAP pro-
teins from the collection individually, we were able
to successfully pull down proteins with compara-
ble efﬁciency (1070 proteins pulled down of 1334
attempts, or 79%). We conclude that immunopre-
cipitations in the multiplex format are an effective
method of efﬁciently purifying TAP fusions from
the collection.
Discussion
In this paper, we have described the construction
of two collections of yeast strains, both with
C-terminal fusions of most ORFs in the yeast
genome, one with the TAP tag and one with the
GFP tag. The oligonucleotide primer set and the
methods discussed could be used to efﬁciently
construct a new collection with any desired C-
terminal tag and in any desired genetic background.
With the ﬁnal reﬁnements of our methods, a
new collection could be constructed by a small
team in a matter of months, depending on the
degree of completeness and level of veriﬁcation
desired (expression analysis and reconstruction of
our collections took several additional months).
Furthermore, many of the methods described could
be modiﬁed for use with other model organisms
that support efﬁcient homologous recombination.
We have conﬁrmed that these collections do
indeed represent a signiﬁcant portion of the pro-
teome, as we have conﬁrmed expression of the
ORF-tag fusions in individual transformants, either
by immunoblot analysis for the TAP collection or
by microscopic analysis for the GFP collection.
Importantly, all fusions are under control of the
native promoter, minimizing the potential for arti-
facts due to overexpression. We therefore believe
that these collections will be useful tools in per-
forming large-scale proteomic experiments. Indeed,
in the course of conﬁrming expression of the fusion
proteins in these collections, we have been able
to obtain valuable information about the absolute
abundance of proteins (TAP collection) as well as
their subcellular localization (GFP collection).
We wished to take proteomic analysis beyond
being descriptive, so we developed methods to
apply standard biochemical experiments in a par-
allel manner. We found that multiplexed immuno-
precipitation could be performed efﬁciently from
extracts derived from individual yeast cultures as
small as 2 ml. This procedure should be easily
modiﬁable in order to perform almost any extract-
based assay in a parallel manner on the proteome.
These collections represent exciting possibilities
for the future in a number of respects. First, it will
be interesting to apply the descriptive methods out-
lined in this paper to experimental situations. One
way in which cells can rapidly respond to envi-
ronmental stimuli is to alter the localization, abun-
dance or post-translational modiﬁcation of proteins,
sometimes without any change in transcriptional
state. One could use the methods described in this
paper to monitor these aspects of many proteins
under various growth conditions or in response to
environmental insults, either with the entire collec-
tions or by examining a speciﬁc subset or family
of proteins.
Second, it will be exciting to see what types of
biochemical and/or microscopic assays are applied
in this high-throughput parallel manner. The ability
to perform immunoprecipitations in a ‘multiplex’
format allows for efﬁcient screening of the entire
proteome with only a handful of experiments.
Any number of post-translational modiﬁcations
can be examined with minor modiﬁcations to this
assay; it will be especially exciting to examine the
dynamic nature of these modiﬁcations in response
to environmental stimuli.
Furthermore, the ability to systematically select
MATa haploid progeny from large-scale yeast
crosses through the use of synthetic genetic array
technology (SGA; Tong et al., 2001) enables either
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of these collections to be efﬁciently crossed to any
desired genetic background. It should be noted that
in previous studies, HIS3 was used for MATa-
speciﬁc selection in the ‘magic marker’ MATα
parent strain (Tong et al., 2001); because the TAP
and GFP strains were constructed with the HIS3
marker, an alternative marker (e.g. LEU2) must be
used in any MATα strains crossed to our collections
for SGA assays. This permits the examination of
how different mutations impact global localization,
abundance or perhaps post-translational modiﬁca-
tions, or could be used to sensitize the strain back-
ground to various chemical or environmental stim-
uli. One could also cross the TAP collection with a
strain or strains containing an ORF tagged with a
different epitope, thereby enabling high-throughput
IP Western experiments to identify protein–protein
interactions.
Worthy of mention is the ease and accessibility
to high-throughput experimentation that these col-
lections provide. Although we employed the use
of robotics and other high-throughput equipment
to construct these collections, it is possible to efﬁ-
ciently utilize these reagents with simply a handful
of multi-channel pipettors and a 96-well pinning
tool. We therefore hope that these collections will
open the door to systematic proteomic analysis by
a wider range of laboratories.
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